This person is not registered. Is this you?


Profile Details
Helen Chen
Affiliations:

National Cancer Institute,

 
, US
Phone: 301-496-8798
Fax: 301-402-0428
My Blogs:
My Twitter Hashtags:
@DrSerenaHChen
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Biology, Cancer Biology, Cell Biology, Drug Design, Oncology, Pharmacology, Stem Cells
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 2963 / 3065 (What's this?)
Accomplish Score: 44
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 33
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (14 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 5 (30 / 0)
  • Vinca alkaloids, the well-known tubulin-binding agents, are widely used for the clinical treatment of malignant tumors. ()
  • INTRODUCTION: miR-99a-5p, known to play an important role in mammalian target of rapamycin (mTOR) regulation, is downregulated in human bladder cancer. ()
  • OBJECTIVES: Single nucleotide polymorphisms in microRNAs (microRNA-196a2 rs11614913, microRNA-146a rs2910164, microRNA-149 rs2292832 and microRNA-499 rs3746444) have been inconsistently associated with risk for oral squamous cell cancer (OSCC). ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.